Compare two treatments for Guillain-Barré nerve weakness
Treatments studied
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study compares immunoadsorption (a blood-filtering treatment) versus intravenous immunoglobulin (IVIG) to see which works better and is safer for Guillain-Barré syndrome. It may help you by testing treatments commonly used to reduce nerve damage and improve recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Have a diagnosis of Guillain-Barré syndrome (GBS)
- Symptoms started within the last 2 weeks
- Be 18 to 60 years old
- Your GBS severity is high (Hughes score 3 or more)
- Be able to understand the study and sign consent (you or a legal representative)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether an inpatient rehabilitation program can help people with Guillain-Barré syndrome. It may be useful if you need structured therapy and support during recovery.
This trial tests whether noninvasive breathing support (like a mask or nasal prongs) can help people with Guillain-Barré syndrome who have trouble breathing. It aims to see if this approach can avoid the need for a breathing tube.
This trial tests a new medicine, tanruprubart (also called ANX005), for people with Guillain-Barré syndrome. It aims to see if the drug can help improve recovery when given soon after symptoms start.
This study tests if ultrasound can find nerve problems in people with Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyneuropathy (CIDP), and if it helps doctors diagnose and predict outcomes early.
This study tests a high-tech rehab program using robots and advanced tools to help people recover from acute neuromuscular diseases. It aims to see if this approach improves leg strength and mobility better than standard care.
This study tests whether immunoadsorption works as well as plasma exchange to improve symptoms in people with Guillain-Barré syndrome. The goal is to find which treatment helps recovery and is safer for patients.
Hear when a new Guillain Barré Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.